
Chairman of Echo Therapeutics Scientific Advisory Board, ...
Company begins transformative 2010 poised to grow revenue...
Echo is developing its PreludeTM SkinPrep System to allow for painless and significantly enhanced skin permeation that will enable both needle-free drug delivery and analyte extraction. Utilizing this technology, Echo is also developing its needle-free SymphonyTM tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for use in hospital critical care units and for people with diabetes.

Echo Therapeutics: Building a brighter future
for diabetes care with